aldosterone has been researched along with Mitral Valve Insufficiency in 16 studies
Mitral Valve Insufficiency: Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown." | 9.27 | A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease. ( Duran, SH; Jung, S; Newhard, DK; Winter, RL, 2018) |
| "The effects of sacubitril/valsartan (S/V) on the renin-angiotensin-aldosterone system (RAAS) in dogs with cardiomegaly secondary to myxomatous mitral valve disease (MMVD) are currently unknown." | 5.27 | A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease. ( Duran, SH; Jung, S; Newhard, DK; Winter, RL, 2018) |
| "Pimobendan has a dual mechanism of action: it increases myocardial contractility by increasing calcium sensitization to troponin C and it promotes vasodilation by inhibiting PDEIII." | 1.34 | Effects of pimobendan for mitral valve regurgitation in dogs. ( Hara, A; Kanno, N; Kano, R; Kawasaki, M; Kuse, H; Sasaki, Y, 2007) |
| "Furosemide was added after the 3-week examination, and at 6 months, dogs had received furosemide for at least 4 months." | 1.29 | Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation. ( Häggström, J; Hansson, K; Karlberg, BE; Kvart, C; Madej, A; Olsson, K, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (43.75) | 18.7374 |
| 1990's | 5 (31.25) | 18.2507 |
| 2000's | 1 (6.25) | 29.6817 |
| 2010's | 3 (18.75) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Newhard, DK | 1 |
| Jung, S | 1 |
| Winter, RL | 1 |
| Duran, SH | 1 |
| Yata, M | 1 |
| Kooistra, HS | 1 |
| Beijerink, NJ | 1 |
| Yiu, KH | 1 |
| Ng, WS | 1 |
| Chan, D | 1 |
| Sit, KY | 1 |
| Wong, A | 1 |
| Lee, CW | 1 |
| Chum, HL | 1 |
| Cheng, WY | 1 |
| Pun, CT | 1 |
| Ho, KL | 1 |
| Chen, Y | 1 |
| Ho, LM | 1 |
| Kumana, CR | 1 |
| Cheung, HL | 1 |
| Chung, MC | 1 |
| Lau, CP | 1 |
| Au, WK | 1 |
| Tse, HF | 1 |
| KUKES, VG | 1 |
| BOJS, GE | 1 |
| CONN, HL | 2 |
| Kanno, N | 1 |
| Kuse, H | 1 |
| Kawasaki, M | 1 |
| Hara, A | 1 |
| Kano, R | 1 |
| Sasaki, Y | 1 |
| Pedersen, HD | 2 |
| Häggström, J | 2 |
| Hansson, K | 2 |
| Karlberg, BE | 2 |
| Kvart, C | 2 |
| Madej, A | 1 |
| Olsson, K | 2 |
| Vuolteenaho, O | 1 |
| Olsen, LH | 1 |
| Mow, T | 1 |
| Christensen, NJ | 1 |
| Kopylova, VA | 1 |
| Giliazutdinova, ZSh | 1 |
| Novikov, VM | 1 |
| Prachar, H | 1 |
| Amano, Y | 1 |
| Abe, T | 1 |
| Matsui, N | 1 |
| Genest, J | 1 |
| Granger, P | 1 |
| De Champlain, J | 1 |
| Boucher, R | 1 |
| Kinoshita, M | 1 |
| Detweiler, DK | 1 |
| McGiff, J | 1 |
| Luchi, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Beneficio Del Bloqueo Del Sistema Renina-angiotensina Sobre la evolución clínica y el Remodelado Ventricular Tras la colocación de Una prótesis percutánea aórtica (RASTAVI)[NCT03201185] | Phase 4 | 194 participants (Actual) | Interventional | 2018-02-10 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for aldosterone and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Endocrine factors in congestive heart failure.
Topics: Aged; Aldosterone; Angiotensin II; Animals; Blood Pressure; Body Weight; Diet, Sodium-Restricted; Do | 1968 |
1 trial available for aldosterone and Mitral Valve Insufficiency
| Article | Year |
|---|---|
A prospective, randomized, double-blind, placebo-controlled pilot study of sacubitril/valsartan (Entresto) in dogs with cardiomegaly secondary to myxomatous mitral valve disease.
Topics: Aldosterone; Aminobutyrates; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pr | 2018 |
14 other studies available for aldosterone and Mitral Valve Insufficiency
| Article | Year |
|---|---|
Cardiorenal and endocrine effects of synthetic canine BNP1-32 in dogs with compensated congestive heart failure caused by myxomatous mitral valve disease.
Topics: Aldosterone; Animals; Cross-Over Studies; Dog Diseases; Dogs; Furosemide; Heart Failure; Heart Valve | 2019 |
Improved prognosis following renin-angiotensin-aldosterone system blockade in patients undergoing concomitant aortic and mitral valve replacement.
Topics: Aged; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aorti | 2014 |
[ON USE OF THE BLOCKING AGENT ALDOSTERONE].
Topics: Aldosterone; Aortic Valve; Diuretics; Heart Failure; Humans; Hyperaldosteronism; Mitral Valve Insuff | 1963 |
DISTRIBUTION OF BODY SODIUM, POTASSIUM, AND WATER AND THE EXCRETION OF ALDOSTERONE IN DOGS WITH SPONTANEOUS HEART FAILURE.
Topics: Aldosterone; Animals; Ascites; Dog Diseases; Dogs; Edema; Heart Failure; Humans; Mitral Valve Insuff | 1965 |
Effects of pimobendan for mitral valve regurgitation in dogs.
Topics: Aldosterone; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiotonic Agents; Catecholamines; | 2007 |
Effects of mild mitral valve insufficiency, sodium intake, and place of blood sampling on the renin-angiotensin system in dogs.
Topics: Aldosterone; Animals; Controlled Clinical Trials as Topic; Diet, Sodium-Restricted; Dog Diseases; Do | 1996 |
Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Dog Dis | 1996 |
Effects of naturally acquired decompensated mitral valve regurgitation on the renin-angiotensin-aldosterone system and atrial natriuretic peptide concentration in dogs.
Topics: Aldosterone; Angiotensin II; Animals; Atrial Natriuretic Factor; Blood Pressure; Creatinine; Dog Dis | 1997 |
Neuroendocrine changes in Dachshunds with mitral valve prolapse examined under different study conditions.
Topics: Aldosterone; Animals; Dog Diseases; Dogs; Eating; Epinephrine; Fasting; Humans; Hydrocortisone; Magn | 1999 |
[Mineralocorticoid function of the adrenal cortex in pregnancies complicated by mitral valve disease and pulmonary edema].
Topics: Adrenal Cortex; Adult; Aldosterone; Female; Humans; Mitral Valve Insufficiency; Pregnancy; Pregnancy | 1979 |
[Changes in PTCA. A model of ischemia in humans].
Topics: Adenosine Triphosphate; Adult; Aged; Aldosterone; Angina Pectoris; Angioplasty, Balloon, Coronary; A | 1991 |
[Mitral valve disease and atrial natriuretic polypeptide].
Topics: Aldosterone; Atrial Natriuretic Factor; Extracorporeal Circulation; Heart Valve Prosthesis; Humans; | 1987 |
Studies on cardiac output to blood volume, and renal circulation in chronic congestive heart failure.
Topics: Adult; Aged; Aldosterone; Arteriosclerosis; Blood Pressure; Blood Volume; Cardiac Output; Chronic Di | 1968 |
Why we have gone to the dogs.
Topics: Aldosterone; Animals; Cardiac Output; Dog Diseases; Dogs; Exercise Test; Guanethidine; Heart; Heart | 1966 |